April 19, 2014

Why is the CDC and FDA Still Recommending the Failed Whooping Cough Vaccine?

FDA FAIL Why is the CDC and FDA Still Recommending the Failed Whooping Cough Vaccine?

Health Impact News

2013 was the year the CDC and FDA finally admitted there were problems with the pertussis (whooping cough) vaccine.

When cases of whooping cough spiked in 2012, the media and medical community was quick to rush in and blame unvaccinated children. The data, however, could not support that claim.

In 2013, there were two major research papers published documenting the failure of the pertussis vaccine. I don’t believe the first one, published in early 2013, received any mainstream media exposure at all, while the second one, later in the year, was back-page news. However, both of these studies should have been headline stories.

The first study reported in early 2013 that researchers had found the first U.S. evidence of vaccine-resistant pertussis. The same phenomenon had been observed in other countries, and research showing that pertussis was developing immunity against the current pertussis vaccine being given to children should have made headline news. But of course, it did not.

Lisa Schnirring from the Center for Infectious Disease Research & Policy at the University of Minnesota summarized the research:

Researchers in other countries have found evidence that circulating strains of Bordetella pertussis have adapted to the acellular vaccine, and researchers today reported similar findings for the first time in US kids, based on genetic analysis of isolates from hospitalized children.

Infectious disease experts have been eyeing waning immunity from acellular pertussis vaccines as a contributor to increasing numbers of cases of pertussis (whooping cough) in several countries, and evidence is mounting that another factor fueling the outbreaks could be that the bacteria are adapting to the vaccine.

The US researchers, including a scientist from the US Centers for Disease Control and Prevention (CDC), described their findings in a letter in the New England Journal of Medicine. (Full story here.)

Note that one of the scientists in this study was from the CDC.

Then, later in 2013, the FDA published a study they had conducted on the pertussis vaccine, admitting that cases of whopping cough were increasing among a highly vaccinated public. They studied the effect of the vaccine on baboons, and found out that vaccinated baboons still carried around whooping cough in their throats, spreading it to others.  The N.Y. Times actually reported on this in their “Health Section”.

So both the CDC and the FDA were aware in 2013 that the whooping cough vaccine was not effective, and yet it is still part of the vaccine schedule. Why?

Could it be because the vaccine is part of a combo vaccine, along with diphtheria and tetanus, and that it therefore represents too great of a financial loss for the drug manufacturers to stop using it?

A report last month (January 2014) from Europe revealed that new whooping cough vaccines are in development, as the World Health Organization has also admitted that the pertussis vaccine no longer works. In the U.S., however, unvaccinated children are still being blamed in the mainstream media for the increase in whooping cough cases. (Just do an internet search for “whooping cough unvaccinated” to see this currently happening.)

Since the U.S. Congress has given vaccine manufacturers total legal immunity from being sued for faulty vaccines or injuries and deaths caused by them, a law upheld by the Supreme Court in 2011, there is no legal basis to stop the ineffective whooping cough vaccine from being injected into children. To stop it would cost billions of dollars in vaccine revenues for the next couple of years as they try to develop a new vaccine to replace the current ineffective pertussis vaccine.

And if one is tempted to think that those who manufacture these vaccines would never keep a defective product on the market knowingly, think again. Twenty percent of all white collar corporate crime is now committed in the pharmaceutical industry, with every major vaccine manufacturer now a convicted criminal. A recent editorial written in the British Medical Journal chronicled how the fines levied against this criminal activity is not sufficient enough to prohibit the companies from continuing to act like criminals. (See: BMJ: Escalating Criminal Behavior by Pharmaceutical Companies due to Insufficient Penalties)

As for the government stepping in to protect the public from a failed vaccine? The story of how Julie Gerberding, the head of the CDC from 2002 through 2009, left government to become the president of Merck’s Vaccine division, a $5 billion dollar a year operation, and the supplier of the largest number of vaccines the CDC recommends, pretty much says it all.

See Also:

Pertussis Vaccine Failure is not Just Modern but Historical: Vaccine has Never Been Effective

 

Dissolving Illusions: Disease, Vaccines, and The Forgotten History
by Dr. Suzanne Humphries and Roman Bystrianyk

Cover 682x1024 Why is the CDC and FDA Still Recommending the Failed Whooping Cough Vaccine?

Free Shipping Available!
Learn More

  Copyright 2014 Health Impact News – permission to reprint fully granted. Links back fully appreciated.

0 commentsback to post

Other articlesgo to homepage

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

Congressman Bill Posey’s strong resolve and demands for transparency were evident as he discussed the Center for Disease Control (CDC)’s handling of vaccine safety studies which affect “our most precious resource in our nation – our children.” The 30-minute interview, conducted by vaccine industry watchdog, PhD biochemist Brian Hooker, delves into what Posey called “the incestuous relationship between the public health community and the vaccine makers and public officials.”

The Florida legislator, known as “Mr. Accountabililty,” did not mince words when criticizing current and past CDC officials including indicted fraudster Dr. Poul Thorsen; CDC director turned Merck Vaccine President Dr. Julie Gerberding; and the agency’s current spokesperson regarding autism and vaccines, Dr. Coleen Boyle.

Congressman Posey said, “The CDC can’t be trusted regarding investigating vaccine safety. Huge conflict of interest. I think the CDC should be investigated.”

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

In an interview with Dr. Bernard Dalbergue, a former pharmaceutical industry physician with Gardasil manufacturer Merck, he predicts that Gardasil will become the greatest medical scandal of all time. Dr. Dalbergue believes that at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill young girls, serves no other purpose than to generate profit for the manufacturers.

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

An important new book by a recognized medical research expert describes Big Pharma as akin to the Mafia. In an interview conducted by our colleagues at ANH-Europe, Dr. Peter C. Gøtzsche exposes the flaws of the drug approval system, our reliance on dangerous drugs, and the deadly co-dependence between regulators and industry. Dr. Gøtzsche is co-founder of the highly respected Cochrane Collaboration and Cochrane Reviews, a leading journal of evidence-based medicine. The interview is particularly timely now that the FDA has decided to remove restrictions on the dangerous drug Avandia.

Dr. Gøtzsche’s new book, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare, points out that the pharmaceutical industry is allowed to test their own drugs, and thus effectively be their own judge. He calls this a threat to safe medicine and asks for open access to all research data, including raw data, because otherwise, data can be easily suppressed and conclusions manipulated by industry.

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical marijuana, or cannabis, is legal in 20 US states, where it is used for a variety of medical conditions such as mood disorders, pain disorders, multiple sclerosis, and even cancer. Parents of children with epilepsy met at a news conference to share their dismay that Governor Mark Dayton refuses to legalize medical marijuana. About 85 percent to 95 percent of Americans are in favor of medical cannabis, and nearly 60 percent are in favor of legalizing marijuana. Cannabis shows outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals, according to a study published recently in the Journal of the American Medical Association.

A team of researchers at the University of Pittsburgh Medical Center examined the boards of the 50 largest drug companies by global sales (excluding three companies that were not publicly traded). The researchers found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one. All told, the research team found that 41 of the companies’ 2012 board members held leadership positions at academic medical centers. Six of the 41 were pharmaceutical company executives who served on hospital boards of directors or held other leadership posts.

The authors wrote that when academic medical leaders serve on pharmaceutical company boards, it can lead to conflicts not only for individuals, but for the critically important health care institutions they guide.

read more


Get the news right in your inbox!